Clinical Trials Logo

Filter by:
NCT ID: NCT02163343 Suspended - Clinical trials for Fractured Neck of Femur

Serum Metal Ion Levels in Patients Who Underwent Cathcart/Corail Hemiarthroplasty for Fractured Neck of Femur

Start date: June 2014
Phase:
Study type: Observational

Elevated serum metal ions are well recognized in metal-on-metal articulations in total hip replacements. The objective of the study is to see if the Cathcart / Corail device implanted during a hemiarthroplasty (replacement of one half of the hip joint) results in elevated serum metal ion levels (cobalt & chromium) and to see if there is an association between size of Cathcart head used and metal ion levels.

NCT ID: NCT02140684 Suspended - Asthma Clinical Trials

Exhaled Nitric Oxide in Asthma Management

Start date: March 2012
Phase: N/A
Study type: Observational

This study will compare the absolute and relative effectiveness of managing real-life asthma with and without the use of NIOX MINO® and NIOX Flex® to measure exhaled nitric oxide (eNO) as a marker of underlying airway inflammation to guide appropriate management. As exhaled nitric oxide responds rapidly to environmental changes and can act as a marker of underlying inflammation it is proposed that incorporating eNO monitoring into routine asthma management treatment allows strategies to be more accurately tailored to the patients needs, increasing the probability of good asthma control.

NCT ID: NCT01997450 Suspended - Clinical trials for Influenza Vaccine Effectiveness

A Case Control Study of the Effectiveness of Q/LAIV Versus Inactivated Influenza Vaccine and No Vaccine in Subjects 2-17 Years of Age

ICICLE
Start date: December 2, 2013
Phase:
Study type: Observational

This is a post-marketing case-controlled study of the effectiveness of a quadrivalent live attenuated influenza vaccine (Q/LAIV/FluMist® Quadrivalent) versus Inactivated Influenza Vaccine (IIV) and No Vaccine in subjects 2-17 years of age.

NCT ID: NCT01987687 Suspended - Clinical trials for Area Under Curve [N06.850.520.830.200]

Effect of Timing of a Post-exercise Oral Glucose Tolerance Test on Glycaemic Control.

Start date: November 2016
Phase: N/A
Study type: Interventional

Postprandial glycaemic control is an important risk factor for the development of type 2 diabetes, cardiovascular disease and all-cause mortality. Previous research has demonstrated that exercise performed in the postprandial state paradoxically results in a deterioration in glucose tolerance in the immediate post-exercise period (Gonzalez et a. 2013; Gonzalez and Stevenson 2013). This study aims to assess the timecourse of this post-exercise effect.

NCT ID: NCT01962857 Suspended - Obesity Clinical Trials

Effect of 4 Weeks of Shuttle Run Training on Insulin Sensitivity in Sedentary Men

Start date: October 2013
Phase: N/A
Study type: Interventional

A number of studies have shown that short duration, high intensity interval training can improve health-related outcomes, such as insulin sensitivity and cardiorespiratory fitness. However, these often use specialized equipment, such as cycle ergometers, which makes it difficult to roll these interventions out for wide-scale use in the general population. This study aims evaluate the effects of a high intensity shuttle running intervention on insulin sensitivity, fitness and related cardiometabolic risk factors in men who are currently inactive. Participants will be randomized into intervention (4 weeks of shuttle running) and control groups. We hypothesize that the shuttle running programme will result in improved insulin sensitivity, fitness and increased fat oxidation at rest compared with the control group.

NCT ID: NCT01921998 Suspended - Lymphoma Clinical Trials

Development of a Biomarker Directed Strategy to Ameliorate Common Toxicities From Conventional Chemotherapy

BioACT
Start date: October 2013
Phase: N/A
Study type: Observational

Side effects from chemotherapy can be severe in some patients leading to admission to hospital, a worse quality of life and delays in subsequent doses of chemotherapy. A blood test that could predict patients who will go on to develop severe side effects could be useful and might allow early intervention with medicines to reduce the severity of the symptoms and prevent admission to hospital. This study will collect blood samples from patients with lymphoma or sarcoma who are receiving chemotherapy (with an expected admission rate for neutropenic sepsis, one of the side effects that most commonly results in hospital admission, of less than 20%). It will assess whether changes in blood proteins ("biomarkers") taken 2 days after the 1st chemotherapy can predict subsequent severe side effects throughout the 4 months of chemotherapy. In addition the investigators will collect data on quality of life and contact with medical professionals to assess the costs of chemotherapy toxicity to both the patient and health service. This will allow us in the future to model the cost effectiveness of using biomarkers in this manner to try and reduce chemotherapy toxicity.

NCT ID: NCT01891825 Suspended - Atrial Fibrillation Clinical Trials

Persistent Atrial Fibrillation Ablation Trial

PAAT
Start date: September 2014
Phase: N/A
Study type: Interventional

Persistent atrial fibrillation (AF) is a common and distressing condition, that can cause significant symptoms. AF ablation is a recognised technique to treat persistent AF, but can be technically difficult. This study compares percutaneous ablation to thoracoscopic surgical AF ablation.

NCT ID: NCT01887457 Suspended - Aspergillosis Clinical Trials

Individualisation of Voriconazole Antifungal Therapy Antifungal Therapy

PIVOTAL
Start date: September 2014
Phase: Phase 2
Study type: Interventional

This is a trial to determine whether giving a patient a tailored dose of voriconazole is safe and effective.

NCT ID: NCT01337518 Suspended - Prostatic Neoplasm Clinical Trials

A Phase 1a/1b Study to Evaluate the Safety of EZN-4176, in Adult Patients With Castration-Resistant Prostate Cancer

Start date: March 2011
Phase: Phase 1
Study type: Interventional

This study will evaluate an experimental drug called EZN-4176 to determine the anticancer effects when it is given to patients with an advanced form of prostate cancer called castration-resistant prostate cancer (CRPC). Goals of this phase I study include finding out the dose of EZN-4176 that can be safely given without serious side effects and to determine the amount of EZN-4176 that should be given in future studies.

NCT ID: NCT01273779 Suspended - Severe Sepsis Clinical Trials

Safety and Efficacy of Talactoferrin Alfa in Patients With Severe Sepsis

OASIS
Start date: June 2011
Phase: Phase 2/Phase 3
Study type: Interventional

Study will evaluate the safety and potential benefit of talactoferrin (recombinant human lactoferrin) as an addition to the standard care for severe sepsis.